| Old Articles: <Older 5441-5450 Newer> |
 |
The Motley Fool July 19, 2005 W.D. Crotty |
The HP Way? Cutting Staff by 10% Hewlett-Packard says it's all about growth and reduced costs.  |
The Motley Fool July 19, 2005 David Meier |
Ford: Too Late to the Party The GM and Chrysler incentive programs take their toll. Ford's CEO is right to say he wants to attack the automotive company's cost structure.  |
The Motley Fool July 19, 2005 Nathan Parmelee |
One Cool Deal for Heinz Its acquisition of Nancy's is a small move but a solid decision. Is it important to investors that Heinz acquired a company with $64 million in sales?  |
The Motley Fool July 19, 2005 Stephen D. Simpson |
Waiting for Boston Scientific's Second Act The market for drug-coated stents is still lucrative, but BSX needs to deliver on its R&D efforts for long-term success. Investors, take note.  |
The Motley Fool July 19, 2005 Tom Taulli |
Stanley Works Gets High Five From Investors Stanley Works puts together a rare thing: an acquisition that Wall Street approves of.  |
The Motley Fool July 19, 2005 Tom Taulli |
Maytag's Whirlwind Recently left for dead, Maytag is now the target of a bidding war. Investors, take note.  |
The Motley Fool July 19, 2005 Steven Mallas |
Madden Sticks Around Electronic Arts signs John Madden to another multi-year commitment. What does it mean to investors?  |
The Motley Fool July 19, 2005 Rick Aristotle Munarriz |
Murdoch in the Mix News Corp. makes a purchase to gain street cred with the wired youth. With Intermix, Rupert Murdoch will savor being the hub of hip -- and he will market accordingly. Investors, take note.  |
Pharmaceutical Executive July 1, 2005 |
Shedding Wings In his latest book, The Only Sustainable Edge: Why Business Strategy Depends on Productive Friction and Dynamic Specialization, John Hagel and co-author John Seely Brown take on the issue of outsourcing. Here's an interview with Hagel.  |
Pharmaceutical Executive July 1, 2005 |
Thought Leader: Getting "Sirius" About Specialty Now, at the helm of Sirius Laboratories, a private company specializing in dermatology, Gary Barnes draws upon his experiences and offers insight into his world of specialty sales force excellence. An interview follows.  |
| <Older 5441-5450 Newer> Return to current articles. |